Chelidonium majus 30C and 200C in induced hepato-toxicity in rats

Homeopathy

Volumn 99, Issue 3, 2010, Pages 167-176

  Banerjee, Antara ^a   Pathak, Surajit ^a   Biswas, Surjyo Jyoti ^a,b   Roy Karmakar, Susanta ^a,c   Boujedaini, Naoual ^a   Belon, Philippe ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

^b Medinipur College Medinipur   (India)

^c JHARGRAM RAJ COLLEGE   (India)

Author keywords

Amelioration; Hepato toxicity; Homeopathy; Immunodetection; Toxicity biomarkers

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; CHELIDONIUM 200C; CHELIDONIUM 30C; CHELIDONIUM EXTRACT; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GELATIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; METALLOPROTEINASE; PHENOBARBITAL; PROTEIN BCL 2; PROTEIN P53; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CHELIDONIUM; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; RAT; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CHELIDONIUM; CHROMOSOME ABERRATIONS; FEMALE; HOMEOPATHY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATERIA MEDICA; P-DIMETHYLAMINOAZOBENZENE; PHENOBARBITAL; PLANT EXTRACTS; RANDOM ALLOCATION; RATS;

EID: 77955265185     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2010.05.008     Document Type: Article

References (38)

1. Rosser C. Homeopathy in cancer care: part 1 - an introduction to "like curing like" Clin J Oncol Nurs 2004, 8(3):324-326.
2. Milazzo S., Russell N., Ernest E. Efficacy of homeopathic therapy in cancer treatment. Eur J Cancer 2006, 42(3):282-289.
3. Downer S.M., Cody M.M., McCluskey P., et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 1994, 309:86-89.
4. Colombo M.L., Bosisio E. Pharmacological activities of Chelidonium majus L. Pharmacol Res 1996, 33:127-134.
5. Furusawa E., Furusawa S., Kroposki M., Cutting W. Higher plants as a source of antiviral agents. Prog Antimicrob Anticancer Chemother 1970, 2:810-817.
6. Lozyuk L.V. Antiviral properties of some compounds of plant origin. Mikrobiol Zh (Kiev) 1977, 39:343-348.
7. Sethi M.L. Screening of benzophenanthridine alkaloids for their inhibition of reverse transcriptase activity and preliminary report on the structure-activity relationships. Can J Pharm Sci 1981, 16:29-34.
8. Horvath J., Kery A., Kulcsar G., Dan P., Nasz J. Antiviral effect of Chelidonium extracts. Proc Int Congr Chemother 1983, 9:106-124.
9. Kery R.Y., Horvath J., Nasz I., Verzar-Petri G., Kulcsar G., Dan P. Antiviral alkaloid in Chelidonium majus L. Acta Pharm Hung 1987, 57:19-25.
10. Boericke W. Pocket Manual of Homeopathic Meteria Medica 1976, Sett Dey and Co., Calcutta. Indian edn.
11. Clarke J.H. A Dictionary of Practical Materia Medica 1978, Vol. I. Jain Publishers and Co., New Delhi.
12. Gebhardt R. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung 2003, 53(12):823-830.
13. Riley D. Contemporary homoeopathic drug provings. J Am Inst Homeopath 1994, 87:161-165.
14. Biswas S.J., Khuda-Bukhsh A.R. Effect of homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Complement Altern Med 2002, 2:4-12.
15. Biswas S.J., Bhattacharjee N., Khuda-Bukhsh A.R. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food Chem Toxicol 2008, 46(5):1474-1487.
16. Biswas S.J., Khuda-Bukhsh A.R. Cytotoxic and genotoxic effects of the azodye p-dimethylaminoazobenzene in mice: a time course study. Mutat Res 2005, 587:1-8.
17. International Agency for Research on Cancer (IARC) IARC monographs program on the evaluation of carcinogenic risks to human. Lyons Available at. http://193.51.164.11/default/html.
18. Khuda-Bukhsh A.R. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003, 253:339-345.
19. Khuda-Bukhsh A.R. Laboratory Research in Homeopathy: Pro. Integr Cancer Ther 2006, 5(4):1-13.
20. Pathak S., Khuda-Bukhsh A.R. Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethylaminoazobenzene and phenobarbital. Exp Mol Pathol 2007, 83(1):104-111.
21. Pathak S., Das J.K., Biswas S.J., Khuda-Bukhsh A.R. Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem 2006, 258:121-131.
22. Gay R.J., Mccomb R.B., Browers G.N. Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem 1968, 14:740-753.
23. Szasz G. Reaction rate method for gamma-glutamyl transferase activity in serum. Clin Chem 1976, 22:2051-2055.
24. Chance B., Maehly A.C. Assay of catalase and peroxidase. Meth Enzymol 1955, 2:764-775.
25. Billings P.C., Habres J.M., Liao D.C., Tuttle S.W. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 1991, 51:5539-5543.
26. Magi B., Bini L., Marzocchi B., Liberatori S., Raggiaschi R., Pallini V. Immunoaffinity identification of 2-DE separated proteins. Methods in Molecular Biology 1999, Vol. 112:313-318. Humana Press, New Jersey. J.L. Andrew (Ed.).
27. Fisher R.A., Yates F. Statistical Tables for Biological, Agricultural and Medical Research 1953, Oliver and Boyd, Edinburgh. 4th edn.
28. Biswas S.J., Pathak S., Khuda-Bukhsh A.R. Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: a time course study. Mutat Res 2004, 563:1-11.
29. Plaa G.L., Amdun A.M., Doull J., Klasser C.D. Toxic responses of the liver 1991, Pergamon Press. 4th edn.
30. Timbrell J.A. Principles of biochemical toxicology 1991, Taylor and Francis, London.
31. Vinitha R., Thangaraju M., Sachdanandam P. Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma. Jpn J Med Sci Biol 1995, 48:145-156.
32. Bain P.J., Latimer K.S., Mahaffey E.A., Prasse K.W. Duncan and Prasse's veterinary medicine, liver clinical pathology 2003, Iowa State Press, Ames, pp. 193-214. 4th edn.
33. Valentine B.A., Blue J.T., Shelley S.M., Cooper B.J. Increased serum alanine aminotransferases activity associated with muscle necrosis in the dog. J Vet Intern Med 1990, 4(3):140-143.
34. Stockham S.L., Scott M.A. Fundamentals of veterinary clinical pathology 2002, Iowa State University Press, Ames, pp. 434-459.
35. Khuda-Bukhsh A.R. Potentized homeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med 1997, 5:43-46.
36. De Oliveira C.C., De Oliveira S.M., Goes V.M., Probst C.M., Kreiger M.A., Buchi D.F. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem 2008, 104(4):1364-1377.
37. Hughes S.L., Smith A.C., Relton C. Homeopathy service in an NHS hospital breast cancer clinic: outcome study. Breast Cancer Res 2008, 10.1186/bcr1977.
38. Jonas W.B., Gaddipati J.P., Rajeshkumar N.V., et al. Can homeopathic treatment slow prostate cancer growth?. Integr Cancer Ther 2006, 5(4):343-349.